CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Practice Management

 

Alzheimer’s Differing Effects on Male, Female Brains

By Joe Van Acker | November 27, 2012

CHICAGO — Brain maps created with multiple MRIs reveal that Alzheimer’s disease affects men and women’s brains differently, according to a study presented Monday at RSNA 2012.

Maria Vittoria Spampinato, MD, associate professor at the Medical University of South Carolina, said the study could change the way the disease is treated and the way that new treatments are developed. The researchers used three MRIs of each patient’s brain to create the brain maps: one taken a year before their Alzheimer’s was identified, one at the time of diagnosis and one a year after the diagnosis.

(MORE: MRI, PET Aids in Predicting Progression of Alzheimer’s)

“These imaging techniques are also used to measure the severity [of the disease] and treatment response in clinical trials, so we want to provide information that is accurate,” she said.

Some sex-based differences in the disease’s effects were already known. Men and women experience effects in terms of risk, cognition and behavior, with women being more prone to depression and men to aggression.

But according to Spampinato, men and women also experience a different pattern of brain atrophy. She and her colleagues analyzed data collected on 109 patients over a five-year period and discovered that men and women undergo different changes in brain structure.

The patients’ data were recorded as they progressed from mild cognitive impairment to Alzheimer’s disease. Spampinato’s study focused on MRIs taken one year prior to diagnosis, at the time of diagnosis and one year after diagnosis. Analysis of these images reveals that the disease tends to strike women earlier, but is more aggressive in men.

One area of the brain particularly important to the study is the hippocampus, a region associated with memory known to shrink as a result of Alzheimer’s disease.

Twelve months before being diagnosed with Alzheimer’s disease, females had smaller hippocampi than men. A year after diagnosis, however, there was no difference, meaning that men lost a greater volume in this part of the brain more quickly than their female counterparts.

Spampinato’s hope is that, by providing more information about how Alzheimer’s affects people differently, the study can lead to more successful methods of treating the disease. She said there are two main questions being asked by the research community.

“Can we predict which individuals are at high risk of developing Alzheimer’s?” she asked. “The next question is, Can we possibly stop this decline? Can we find a cure?”

 

Alzheimer's affect on men's, women's brains

Figure 1. Shown in blue are areas of relatively greater brain volume in males compared to females 12 months before Alzheimer’s disease diagnosis (Mild Cognitive Impairment) and at the time of Alzheimer’s disease diagnosis (Alzheimer’s disease diagnosis). No areas of greater brain volume were found in females than males.

Alzheimer's in men, women

Figure 2. Shown are areas of brain volume loss found in males (blue) and in females (red) during the 12 months before and during the 12 months after Alzheimer’s disease diagnosis (common areas of volume loss in purple). (Images courtesy RSNA)

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

Related Content

Alzheimer’s Differing Effects on Male, Female Brains

Imaging Shows Active Lifestyle Slows Alzheimer’s

PET Imaging with Amyvid for Alzheimer's

Case Study: PET Imaging with Amyvid for Alzheimer’s

New Alzheimer’s Imaging Test in Use at Mount Sinai

PET, MRI, Cerebrospinal Analysis Best for Alzheimer’s Test

FDDNP-PET Shows Brain Injury in Former NFL Players

MRI, PET Aids in Predicting Progression of Alzheimer’s






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Practice Management
Evidence on Practice Management
Guidelines on Practice Management
Patient Education on Practice Management
Clinical Trials on Practice Management
Practical Articles on Practice Management
Research and Reviews on Practice Management
All "Practice Management" results

CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy